Biocon LimitedNSE: BIOCON

Press Release May 19 2022

· Issued by Biocon Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-may-19-2022-7

Biocon Limited has informed the Exchange about press release dated 19-May-2022 titled "Biocon Biologics and Viatris Launch Abevmy�� (bBevacizumab), Their Third Oncology Biosimilar, in Canada"

View Attachment

6ix hasn’t read this filing yet.

Biocon Limited on 6ix

Earlier from Biocon

Later from Biocon

All Biocon news releases